Stock detail
Natera (NTRA) stock price, chart, and key data
View Natera stock price, chart movement, and headline metrics on Woodstock's stock detail page.

Stock detail
Natera
NTRA · XNAS
$322.91
+1.00%
+$3.20
After hours $323.31 (+0.12%)
Key metrics
52-week range
$9.00 - $28.00
Close price
$319.72
Market cap
$45.2B
P/E ratio
-761.23
Beta
2.36
About the company
Natera Inc
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas.
Analyst rating summary
A current read on analyst sentiment from the insight feed.
Mean target
$419
17
Buy
/ 18
Recent calls
11/09/2026
Roth MKM
Max Masucci
Buy · Price target $405
11/09/2026
Robert W. Baird
Catherine Ramsey Schulte
Buy · Price target $403
11/05/2026
Goldman Sachs
Evie Koslosky
Hold · Price target $360
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app